Assessment of Single-Dose Pharmacokinetics of Oxolinic Acid in Rainbow Trout and Determination of In Vitro Antibacterial Activity Against Pathogenic Bacteria From Diseased Fish.
antimicrobial therapy
oxolinic acid
pharmacokinetics
rainbow trout
tissue residual
Journal
Journal of veterinary pharmacology and therapeutics
ISSN: 1365-2885
Titre abrégé: J Vet Pharmacol Ther
Pays: England
ID NLM: 7910920
Informations de publication
Date de publication:
09 Aug 2024
09 Aug 2024
Historique:
revised:
22
07
2024
received:
26
04
2024
accepted:
24
07
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
9
8
2024
Statut:
aheadofprint
Résumé
In response to the heightened risk of bacterial diseases in fish farms caused by increased demand for fish consumption and subsequent overcrowding, researchers are currently investigating the efficacy and residue management of oxolinic acid (OA) as a treatment for bacterial infections in fish. This research is crucial for gaining a comprehensive understanding of the pharmacokinetics of OA. The present study investigates pharmacokinetics of OA in juvenile rainbow trout. The fish were given a 12 mg kg
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Indian Council of Agricultural Research
Organisme : Indian Council of Agricultural Research (ICAR)
ID : CIBA/AINPFH/2015-16
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Action, S. I. 2020. “World Fisheries and Aquaculture.” Food and Agriculture Organization 2020: 1–244.
AliAbadi, F. S., and P. Lees. 2000. “Antibiotic Treatment for Animals: Effect on Bacterial Population and Dosage Regimen Optimisation.” International Journal of Antimicrobial Agents 14, no. 4: 307–313.
APHA. 2005. Standard Methods for the Examination of Water and Wastewater. 21st ed. Washington DC: American Public Health Association/American Water Works Association/Water Environment Federation.
Archimbault, P., G. Ambroggi, and S. Nicolas. 1988. “Oxolinic Acid in the Trout: Bioavailability and Tissue Residues.” Annals of Veterinary Research 19, no. 1: 39–43.
Austin, B., and D. A. Austin, eds. 1987. “Control of Bacterial Fish Diseases.” In Bacterial Fish Pathogens: Disease in Farmed and Wild Fish, 331–353. Chichester: Ellis Horwood.
Austin, B., J. Rayment, and D. J. Alderman. 1983. “Control of Furunculosis by Oxolinic Acid.” Aquaculture 31: 101–108.
Barnes, A. C., C. S. Lewin, T. S. Hastings, and S. G. Amyes. 1991. “In Vitro Susceptibility of the Fish Pathogen Aeromonas salmonicida to Flumequine.” Antimicrobial Agents and Chemotherapy 35, no. 12: 2634–2635.
Barry, A. L., R. N. Jones, C. Thornsberry, L. W. Ayers, E. H. Gerlach, and H. M. Sommers. 1984. “Antibacterial Activities of Ciprofloxacin, Norfloxacin, Oxolinic Acid, Cinoxacin, and Nalidixic Acid.” Antimicrobial Agents and Chemotherapy 25, no. 5: 633–637.
Blaser, J. U. R. G., B. B. Stone, M. C. Groner, and S. H. Zinner. 1987. “Comparative Study With Enoxacin and Netilmicin in a Pharmacodynamic Model to Determine Importance of Ratio of Antibiotic Peak Concentration to MIC for Bactericidal Activity and Emergence of Resistance.” Antimicrobial Agents and Chemotherapy 31, no. 7: 1054–1060.
Chevalier, R., J. P. Gerard, and C. Michel. 1981. “Distribution et cinetique tissulaire de la flumequine chez la truite arc‐en‐ciel (Salmo gairdneri, Richardson). Recherches de residus [Medicament Veterinaire].” Revue de Médecine Vétérinaire 132: 831–837.
Corum, O., A. Er, D. D. Corum, O. Atik, and K. Uney. 2019. “Pharmacokinetics and Bioavailability of Ceftriaxone in Brown Trout (Salmo trutta fario) after Intravenous and Intramuscular Administration.” Aquaculture 500: 272–277.
Corum, O., E. Terzi, D. D. Corum, O. N. Kenanoglu, S. Bilen, and K. Uney. 2020. “Pharmacokinetic/Pharmacodynamic Integration of Marbofloxacin After Oral and Intravenous Administration in Rainbow Trout (Oncorhynchus mykiss).” Aquaculture 514: 734510.
Corum, O., K. Uney, E. Terzi, et al. 2023. “Effects of Temperature on the Pharmacokinetics, Tissue Residues, and Withdrawal Times of Doxycycline in Rainbow Trout (Oncorhynchus mykiss) Following Oral Administration.” Veterinary Sciences 10, no. 6: 401.
Crumplin, G. C., and J. T. Smith. 1975. “Nalidixic Acid: An Antibacterial Paradox.” Antimicrobial Agents and Chemotherapy 8, no. 3: 251–261.
de Oliveira, T. F., G. A. Queiroz, J. P. Teixeira, H. C. P. Figueiredo, and C. A. G. Leal. 2018. “Recurrent Streptoccoccus agalactiae Infection in Nile Tilapia (Oreochromis niloticus) Treated With Florfenicol.” Aquaculture 493: 51–60.
Ellingsen, O. F., B. Midttun, A. Rogstad, C. Syvertsen, and O. B. Samuelsen. 2002. “Dosage Regime Experiments With Oxolinic Acid and Flumequine in Atlantic Salmon (Salmo salar L) held in Seawater.” Aquaculture 209, no. 1‐4: 19–34.
Endo, T., K. Ogishima, H. Hayasaka, S. Kareko, and S. Ohshima. 1973. “Application of Oxolinic Acid as a Chemotherapeutic Agent Against Infectious Diseases of Fishes. I. Antibacterial Activity, Chemotherapeutic Effects and Pharmacokinetics of Oxolinic Acid in Fishes.” Bulletin of the Japanese Society of Scientific Fisheries 39, no. 2: 165–171.
Endo, T., and M. Onozawa. 1987a. “Effects of pH and Temperature on the Uptake of Oxolinic Acid [5‐Ethyl‐5, 8‐Dihydro‐8‐Oxo‐1, 3‐Dioxolo (4, 5‐g) Quinoline‐7‐Carboxylic Acid] by Goldfish [Carassius auratus].” Bulletin of the Japanese Society of Scientific Fisheries (Japan) 53, no. 4: 551–555.
Endo, T., and M. Onozawa. 1987b. “Effects of Bath Salinity and Number of Fish on the Uptake of Oxolinic Acid by Ayu.” Bulletin of the Japanese Society of Scientific Fisheries 53, no. 4: 557–562.
Endo, T., M. Onozawa, M. Hamaguchi, and R. Kusuda. 1987. “Enhanced Bioavailability of Oxolinic Acid by Ultra‐Fine Size Reduction in Yellowtail, Seriola quinqueradiata.” Bulletin of the Japanese Society of Scientific Fisheries (Japan) 53, no. 10: 1711–1716.
Endo, T., M. Sakuma, H. Tanaka, et al. 1973. “Application of Oxolinic Acid as Chemotherapeutic Agent Against Infectious Diseases in Fishes. II. Explanation of Chemotherapeutic Effects by Whole Body Autobacteriography.” Bulletin Dpn Society of Scientific Fisheries 39: 173–177.
Gabrielsson, J., and D. Weiner. 2001. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Vol. 2000. 3rd ed, 654–659. Stockholm, Sweden: Swedish Pharmaceutical Press.
Glass, G. V., P. D. Peckham, and J. R. Sanders. 1972. “Consequences of Failure to Meet Assumptions Underlying the Fixed Effects Analyses of Variance and Covariance.” Review of Educational Research 42, no. 3: 237–288.
Guidi, L. R., F. A. Santos, A. C. S. Ribeiro, C. Fernandes, L. H. Silva, and M. B. A. Gloria. 2018. “Quinolones and Tetracyclines in Aquaculture Fish by a Simple and Rapid LC‐MS/MS Method.” Food Chemistry 245: 1232–1238.
Haugland, G. T., K. O. Kverme, R. Hannisdal, et al. 2019. “Pharmacokinetic Data Show That Oxolinic Acid and Flumequine Are Absorbed and Excreted Rapidly From Plasma and Tissues of Lumpfish.” Frontiers in Veterinary Science 6: 394.
Hikichi, Y. 1993. “Antibacterial Activity of Oxolinic Acid on Pseudomonas glumae.” Japanese Journal of Phytopathology 59, no. 4: 369–374.
Horsberg. 1999. “Single‐Dose Pharmacokinetics of Flumequine in Halibut (Hippoglossus hippoglossus) and Turbot (Scophthalmus maximus).” Journal of Veterinary Pharmacology and Therapeutics 22, no. 2: 122–126.
Hustvedt, S. O., R. Salte, and T. Benjaminsen. 1989. “Rapid High‐Performance Liquid Chromatographic Method for the Determination of Oxolinic Acid in Fish Serum Employing Solid‐Phase Extraction.” Journal of Chromatography 494: 335–339.
Hustvedt, S. O., R. Salte, and V. Vassvik. 1992. “Combatting Cold‐Water Vibriosis in Atlantic Salmon (Salmo salar L.) with Oxolinic Acid: A Case Report.” Aquaculture 103, no. 3‐4: 213–219.
Ishida, N. 1992. “Tissue Levels of Oxolinic Acid After Oral or Intravascular Administration to Freshwater and Seawater Rainbow Trout.” Aquaculture 102, no. 1‐2: 9–15.
Jacobsen, M. D. 1989. “Withdrawal Times of Freshwater Rainbow Trout, Salmo gairdneri Richardson, After Treatment With Oxolinic Acid, Oxytetracycline and Trimetoprim.” Journal of Fish Diseases 12, no. 1: 29–36.
Kasuga, Y., A. Sugitani, F. Yamada, M. Arai, and S. Morikawa. 1984. “Oxolinic Acid Residues in Tissues of Cultured Rainbow Trout and ayu Fish.” Food Hygiene and Safety Science (Shokuhin Eiseigaku Zasshi) 25, no. 6: 512–516.
Koc, F., K. Uney, M. Atamanalp, I. Tumer, and G. Kaban. 2009. “Pharmacokinetic Disposition of Enrofloxacin in Brown Trout (Salmo Trutta Fario) after Oral and Intravenous Administrations.” Aquaculture 295, no. 1‐2: 142–144.
Madsen, P. O., and P. R. Rhodes. 1971. “Oxolinic Acid, a New Chemotherapeutic Agent in the Treatment of Urinary Tract Infection.” The Journal of Urology 105, no. 6: 870–872.
Mallik, S. K., N. Shahi, R. Pathak, et al. 2023. “Pharmacokinetics and Biosafety Evaluation of a Veterinary Drug Florfenicol in Rainbow Trout, Oncorhynchus mykiss (Walbaum 1792) as a Model Cultivable Fish Species in Temperate Water.” Frontiers in Pharmacology 14: 1033170.
Mallik, S. K., S. Singh, N. Shahi, et al. 2023. “Biosafety, Histological Alterations and Residue Depletion of Feed Administered Anti‐Parasitic Drug Emamectin Benzoate in Golden Mahseer, Tor Putitora (Hamilton, 1822) as a Model Candidate Fish for Sport Fishery and Conservation in Temperate Waters.” Frontiers in Pharmacology 14: 1106124.
Martinsen, B., and T. E. Horsberg. 1995. “Comparative Single‐Dose Pharmacokinetics of Four Quinolones, Oxolinic Acid, Flumequine, Sarafloxacin, and Enrofloxacin, in Atlantic Salmon (Salmo salar) held in Seawater at 10 Degrees C.” Antimicrobial Agents and Chemotherapy 39, no. 5: 1059–1064.
Okocha, R. C., I. O. Olatoye, and O. B. Adedeji. 2018. “Food Safety Impacts of Antimicrobial Use and Their Residues in Aquaculture.” Public Health Reviews 39: 1–22.
Rigos, G., A. E. Tyrpenou, I. Nengas, M. Alexis, and G. M. Troisi. 2004. “The Kinetic Profile of Oxolinic Acid in Sharpsnout Sea Bream, Diplodus puntazzo (Cetti 1777).” Aquaculture Research 35, no. 14: 1299–1304.
Rodgers, C. J., and B. Austin. 1983. “Oxolinic Acid for Control of Enteric red Mouth Disease in Rainbow Trout.” Veterinary Record 112: 83.
Rogstad, A., O. F. Ellingsen, and C. Syvertsen. 1993. “Pharmacokinetics and Bioavailability of Flumequine and Oxolinic Acid After Various Routes of Administration to Atlantic Salmon in Seawater.” Aquaculture 110, no. 3‐4: 207–220.
Samuelsen, O. B. 2006. “Pharmacokinetics of Quinolones in Fish: A Review.” Aquaculture 255, no. 1‐4: 55–75.
Samuelsen, O. B., and Ø. Bergh. 2004. “Efficacy of Orally Administered Florfenicol and Oxolinic Acid for the Treatment of Vibriosis in Cod (Gadus morhua).” Aquaculture 235, no. 1‐4: 27–35.
Samuelsen, O. B., Ø. Bergh, and A. Ervik. 2003. “A Single‐Dose Pharmacokinetic Study of Oxolinic Acid and Vetoquinol, an Oxolinic Acid Ester, in Cod, Gadus morhua L., Held in sea Water at 8°C and In Vitro Antibacterial Activity of Oxolinic Acid Against Vibrio anguillarum Strains Isolated From Diseased Cod.” Journal of Fish Diseases 26, no. 6: 339–347.
Samuelsen, O. B., and A. Ervik. 1997. “Single Dose Pharmacokinetic Study of Flumequine After Intravenous, Intraperitoneal and Oral Administration to Atlantic Halibut (Hippoglossus hippoglossus) Held in Seawater at 9 C.” Aquaculture 158, no. 3‐4: 215–227.
Samuelsen, O. B., and A. Ervik. 1999. “A Single‐Dose Pharmacokinetic Study of Oxolinic Acid and Vetoquinol, an Oxolinic Acid Ester, in Atlantic Halibut, Hippoglossus hippoglossus L., Held in Sea Water at 9°C.” Journal of Fish Diseases 22, no. 1: 13–23.
Samuelsen, O. B., A. Ervik, L. Pursell, and P. Smith. 2000. “Single‐Dose Pharmacokinetic Study of Oxolinic Acid and Vetoquinol, an Oxolinic Acid Ester, in Atlantic Salmon (Salmo salar) Held in Seawater and In Vitro Antibacterial Activity Against Aeromonas salmonicida.” Aquaculture 187, no. 3‐4: 213–224.
Samuelsen, O. B., P. G. Kvenseth, J. H. Andreassen, L. Torkildsen, A. Ervik, and Ø. Bergh. 2003. “The Efficacy of a Single Intraperitoneal Injection of Oxolinic Acid in the Treatment of Bacterial Infections in Goldsinny Wrasse (Ctenolabrus rupestris) and Corkwing Wrasse (Symphodus melops) Studied Under Field and Laboratory Conditions.” Journal of Veterinary Pharmacology and Therapeutics 26, no. 3: 181–186.
Samuelsen, O. B., and B. T. Lunestad. 1996. “Bath Treatment, an Alternative Method for the Administration of the Quinolones Flumequine and Oxolinic Acid to Halibut, Hippoglossus hippoglossus, and In Vitro Antibacterial Activity of the Drugs Against Some Vibrio sp.” Diseases of Aquatic Organisms 27, no. 1: 13–18.
Shahi, N., S. K. Mallik, M. Sahoo, and P. Das. 2013. “Biological Characteristics and Pathogenicity of a Virulent Aeromonas Hydrophila Associated With Ulcerative Syndrome in Farmed Rainbow Trout, Oncorhynchus mykiss (Walbaum).” India Israeli Journal of Aquaculture 65: 926–936.
Shan, Q., J. Fan, J. Wang, X. Zhu, Y. Yin, and G. Zheng. 2018. “Pharmacokinetics of Enrofloxacin After Oral, Intramuscular and Bath Administration in Crucian Carp (Carassius auratus gibelio).” Journal of Veterinary Pharmacology and Therapeutics 41, no. 1: 159–162.
Shiry, N., T. Shomali, S. Soltanian, and M. Akhlaghi. 2019. “Comparative Single‐Dose Pharmacokinetics of Orally Administered Florfenicol in Rainbow Trout (Oncorhynchus mykiss, Walbaum, 1792) at Health and Experimental Infection With Streptococcus iniae or Lactococcus garvieae.” Journal of Veterinary Pharmacology and Therapeutics 42, no. 2: 214–221.
Singh, S., S. K. Mallik, K. Kala, et al. 2021. “Characterization of Flavobacterium columnare From Farmed Infected Rainbow Trout, Oncorhynchus mykiss (Walbaum, 1792) of Central Indian Himalayan Region India.” Aquaculture 544: 737118.
Stamm, J. M. 1989. “In Vitro Resistance by Fish Pathogens to Aquacultural Antibacterials, Including the Quinolones Difloxacin (A‐56619) and Sarafloxacin (A‐56620).” Journal of Aquatic Animal Health 1, no. 2: 135–141.
Stanković, D., A. J. Crivelli, and A. Snoj. 2015. “Rainbow Trout in Europe: Introduction, Naturalization, and Impacts.” Reviews in Fisheries Science & Aquaculture 23, no. 1: 39–71.
Steffenak, I., V. Hormazabal, and M. Yndestad. 1991. “Reservoir of Quinolone Residues in Fish.” Food Additives & Contaminants 8, no. 6: 777–780.
Terzi, E., O. Corum, S. Bilen, O. N. Kenanoglu, O. Atik, and K. Uney. 2020. “Pharmacokinetics of Danofloxacin in Rainbow Trout After Different Routes of Administration.” Aquaculture 520: 734984.
Tsoumas, A., D. J. Alderman, and C. J. Rodgers. 1989. “Aeromonas salmonicida: Development of Resistance to 4‐Quinolone Antimicrobials.” Journal of Fish Diseases 12, no. 5: 493–507.
Ueno, R., M. Okumura, Y. Horiguchi, and S. S. Kubota. 1988. “Levels of Oxolinic Acid in Cultured Rainbow Trout and Amago Salmon After Oral Administration.” Nippon Suisan Gakkaishi 54, no. 3: 485–489.
Verner‐Jeffreys, D., and N. Taylor. 2015. Review of Freshwater Treatments Used in the Scottish Freshwater Rainbow Trout Aquaculture Industry. Pitlochry, Scotland: Scottish Aquaculture Research Forum. Scottish Aquaculture Research Forum. Scottish Aquaculture Research Forum.
Wiegand, I., K. Hilpert, and R. E. Hancock. 2008. “Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances.” Nature Protocols 3, no. 2: 163–175.
Wrigh, D. H., G. H. Brown, M. L. Peterson, and J. C. Rotschafer. 2000. “Application of Fluoroquinolone Pharmacodynamics.” Journal of Antimicrobial Chemotherapy 46, no. 5: 669–683.
Ziv, G. 1976. “Clinical Pharmacology of Oxolinic Acid in Young Dairy Calves.” American Journal of Veterinary Research 37, no. 5: 513–516.